LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.89 | 771.67 | 1478 | 2397 | 0.6164 | 0.4879 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.89 | 771.67 | 1666 | 2397 | 0.6948 | 0.6009 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 24.89 | 771.67 | 1801 | 2397 | 0.7511 | 0.6790 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.11 | 771.67 | 1551 | 2675 | 0.5798 | 0.4758 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.11 | 771.67 | 1758 | 2675 | 0.6572 | 0.5826 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 27.11 | 771.67 | 1907 | 2675 | 0.7129 | 0.6561 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.33 | 771.67 | 1640 | 2939 | 0.5579 | 0.4781 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.33 | 771.67 | 1911 | 2939 | 0.6501 | 0.6000 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 29.33 | 771.67 | 2020 | 2939 | 0.6872 | 0.6467 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.55 | 771.67 | 1742 | 3196 | 0.5449 | 0.4875 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.55 | 771.67 | 2060 | 3196 | 0.6444 | 0.6142 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 31.55 | 771.67 | 2124 | 3196 | 0.6644 | 0.6385 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.78 | 771.67 | 1845 | 3499 | 0.5272 | 0.4913 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.78 | 771.67 | 2143 | 3499 | 0.6124 | 0.5973 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 33.78 | 771.67 | 2259 | 3499 | 0.6455 | 0.6363 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 36.00 | 771.67 | 1936 | 3884 | 0.4984 | 0.4836 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 36.00 | 771.67 | 2300 | 3884 | 0.5921 | 0.5974 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 36.00 | 771.67 | 2379 | 3884 | 0.6124 | 0.6207 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 38.22 | 771.67 | 2043 | 4299 | 0.4752 | 0.4812 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 38.22 | 771.67 | 2428 | 4299 | 0.5647 | 0.5881 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 38.22 | 771.67 | 2476 | 4299 | 0.5759 | 0.6007 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 40.44 | 771.67 | 2158 | 4738 | 0.4554 | 0.4811 | MN20160304_L01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 40.44 | 771.67 | 2571 | 4738 | 0.5426 | 0.5835 | MN20160304_L01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 40.44 | 771.67 | 2596 | 4738 | 0.5479 | 0.5894 | MN20160304_L01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 42.67 | 771.67 | 2344 | 5155 | 0.4546 | 0.5000 | MN20160304_L01 | G09 |